Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis
Open Access
- 1 January 2016
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (33) , 7579-86
Abstract
To summarize and compare the clinical characteristics of drug-induced liver injury (DILI) and primary biliary cirrhosis (PBC). A total of 124 patients with DILI and 116 patients with PBC treated at Shengjing Hospital Affiliated to China Medical University from 2005 to 2013 were included. Demographic data (sex and age), biochemical indexes (total protein, albumin, alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin, indirect bilirubin, alkaline phosphatase, and gamma glutamyltransferase), immunological indexes [immunoglobulin (Ig) A, IgG, IgM, antinuclear antibody, anti-smooth muscle antibody, anti-mitochondrial antibody, and anti-mitochondrial antibodies] and pathological findings were compared in PBC patients, untyped DILI patients and patients with different types of DILI (hepatocellular type, cholestatic type and mixed type). There were significant differences in age and gender distribution between DILI patients and PBC patients. Biochemical indexes (except ALB), immunological indexes, positive rates of autoantibodies (except SMA), and number of cases of patients with different ANA titers (except the group at a titer of 1:10000) significantly differed between DILI patients and PBC patients. Biochemical indexes, immunological indexes, and positive rate of autoantibodies were not quite similar in different types of DILI. PBC was histologically characterized mainly by edematous degeneration of hepatocytes (n = 30), inflammatory cell infiltration around bile ducts (n = 29), and atypical hyperplasia of small bile ducts (n = 28). DILI manifested mainly as fatty degeneration of hepatocytes (n = 15) and spotty necrosis or loss of hepatocytes (n = 14). Although DILI and PBC share some similar laboratory tests (biochemical and immunological indexes) and pathological findings, they also show some distinct characteristics, which are helpful to the differential diagnosis of the two diseases.Keywords
This publication has 13 references indexed in Scilit:
- Diagnosis of primary biliary cirrhosisBest Practice & Research Clinical Gastroenterology, 2011
- Standardization of nomenclature and causality assessment in drug‐induced liver injuryHepatology, 2010
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology, 2009
- Primary biliary cirrhosis # †Hepatology, 2009
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registryHepatology, 2006
- Drug-induced liver injury: Summary of a single topic clinical research conferenceHepatology, 2006
- Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteriaLiver Transplantation, 2000
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990